ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Objective Acuity announces successful pilot study in children with CLN2 Batten disease
May 11, 2021Objective Acuity today announced the completion of a pilot study using OAL's threshold visual acuity test for young children diagnosed with late-infantile neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a form of Batten disease. -
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease
November 26, 2018REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform....
Pharma Sources Insight January 2025
